Jennifer Carver - Net Worth and Insider Trading
Jennifer Carver Net Worth
The estimated net worth of Jennifer Carver is at least $75,362 dollars as of 2024-11-13. Jennifer Carver is the COO of La Jolla Pharmaceutical Co and owns about 12,116 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $75,362. Details can be seen in Jennifer Carver's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Carver has not made any transactions after 2019-01-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Carver
Jennifer Carver Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Carver owns 2 companies in total, including La Jolla Pharmaceutical Co (LJPC) , and Revelation Biosciences Inc (REVB) .
Click here to see the complete history of Jennifer Carver’s form 4 insider trades.
Insider Ownership Summary of Jennifer Carver
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LJPC | La Jolla Pharmaceutical Co | 2019-01-09 | Sr. Vice President & Operations |
| REVB | Revelation Biosciences Inc | 2022-01-10 | director |
Jennifer Carver Latest Holdings Summary
Jennifer Carver currently owns a total of 1 stock. Jennifer Carver owns 12,116 shares of La Jolla Pharmaceutical Co (LJPC) as of January 9, 2019, with a value of $75,362.
Latest Holdings of Jennifer Carver
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LJPC | La Jolla Pharmaceutical Co | 2019-01-09 | 12,116 | 6.22 | 75,362 |
Holding Weightings of Jennifer Carver
Jennifer Carver Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Carver has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 5,000 shares on January 9, 2019, which cost Jennifer Carver around $30,850.
Insider Trading History of Jennifer Carver
- 1
Jennifer Carver Trading Performance
GuruFocus tracks the stock performance after each of Jennifer Carver's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Carver is -8.17%. GuruFocus also compares Jennifer Carver's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Carver within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jennifer Carver's insider trading performs compared to the benchmark.
Performance of Jennifer Carver
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.44 | | | | | |
| Relative Return to S&P 500(%) | -6.94 | | | | | |
Jennifer Carver Ownership Network
Ownership Network List of Jennifer Carver
Ownership Network Relation of Jennifer Carver
Jennifer Carver Owned Company Details
What does La Jolla Pharmaceutical Co do?
Who are the key executives at La Jolla Pharmaceutical Co?
Jennifer Carver is the Sr. Vice President & Operations of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , director & Chief Executive Officer Larry G. Edwards , and Chief Financial Officer Michael S Hearne .
La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.
La Jolla Pharmaceutical Co Insider Transactions
Jennifer Carver Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Carver. You might contact Jennifer Carver via mailing address: 725 Newport Street, Denver Co 80220.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
